Kaichi Nishiwaki
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.
Journal: British journal of haematology
Published: June 10, 2026
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Journal: International journal of clinical oncology
Published: April 11, 2026
Diagnostic delay and clinical outcomes of paroxysmal nocturnal hemoglobinuria: a retrospective cohort study using Japanese claims data.
Journal: International journal of hematology
Published: March 04, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
Journal: Blood cancer journal
Published: February 14, 2026
Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.
Journal: Japanese journal of clinical oncology
Published: December 16, 2025
Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.
Journal: International journal of hematology
Published: August 09, 2025
Comparison of stem cell mobilization methods in multiple myeloma.
Journal: Cytotherapy
Published: June 23, 2025
Area under tacrolimus concentrations predict outcomes after unrelated allogeneic hematopoietic stem cell transplantation.
Journal: International journal of hematology
Published: April 22, 2025
Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.
Journal: Cancers
Published: November 27, 2024
Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.
Journal: International journal of hematology
Published: September 06, 2024
Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.
Journal: Cancer diagnosis & prognosis
Published: August 15, 2024
Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.
Journal: International journal of hematology
Published: August 06, 2024
Last Updated: 09/26/2026